Current and historical daily PE Ratio for AstraZeneca PLC (
BSP:A1ZN34
) from 2020 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. AstraZeneca PLC stock (BSP:A1ZN34) PE ratio as of Apr 26 2024 is 38.99.
More Details
AstraZeneca PLC (BSP:A1ZN34) PE Ratio (TTM) Chart
AstraZeneca PLC (BSP:A1ZN34) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 912
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| AstraZeneca PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | 20.3 | 2024-02-21 | 16.8 |
| 2024-04-24 | 19.1 | 2024-02-20 | 16.8 |
| 2024-04-23 | 19.1 | 2024-02-19 | 16.9 |
| 2024-04-22 | 19.1 | 2024-02-16 | 16.9 |
| 2024-04-19 | 18.6 | 2024-02-15 | 16.3 |
| 2024-04-18 | 18.8 | 2024-02-14 | 16.0 |
| 2024-04-17 | 18.8 | 2024-02-09 | 16.1 |
| 2024-04-16 | 18.8 | 2024-02-08 | 16.7 |
| 2024-04-15 | 18.6 | 2024-02-07 | 17.4 |
| 2024-04-12 | 18.5 | 2024-02-06 | 17.4 |
| 2024-04-11 | 18.6 | 2024-02-05 | 17.0 |
| 2024-04-10 | 18.1 | 2024-02-02 | 17.1 |
| 2024-04-09 | 17.8 | 2024-02-01 | 17.2 |
| 2024-04-08 | 17.9 | 2024-01-31 | 17.3 |
| 2024-04-05 | 17.9 | 2024-01-30 | 17.4 |
| 2024-04-04 | 17.9 | 2024-01-29 | 17.3 |
| 2024-04-03 | 17.7 | 2024-01-26 | 17.2 |
| 2024-04-02 | 17.7 | 2024-01-25 | 17.2 |
| 2024-04-01 | 17.9 | 2024-01-24 | 17.1 |
| 2024-03-28 | 17.8 | 2024-01-23 | 17.2 |
| 2024-03-27 | 17.8 | 2024-01-22 | 16.7 |
| 2024-03-26 | 17.3 | 2024-01-19 | 17.2 |
| 2024-03-25 | 17.1 | 2024-01-18 | 17.0 |
| 2024-03-22 | 17.4 | 2024-01-17 | 17.3 |
| 2024-03-21 | 17.3 | 2024-01-16 | 17.3 |
| 2024-03-20 | 17.1 | 2024-01-15 | 18.5 |
| 2024-03-19 | 17.6 | 2024-01-12 | 17.6 |
| 2024-03-18 | 17.3 | 2024-01-11 | 17.8 |
| 2024-03-15 | 17.3 | 2024-01-10 | 17.8 |
| 2024-03-14 | 17.5 | 2024-01-09 | 17.7 |
| 2024-03-13 | 17.7 | 2024-01-08 | 17.6 |
| 2024-03-12 | 17.1 | 2024-01-05 | 17.5 |
| 2024-03-11 | 17.6 | 2024-01-04 | 17.7 |
| 2024-03-08 | 17.3 | 2024-01-03 | 17.6 |
| 2024-03-07 | 17.1 | 2024-01-02 | 17.5 |
| 2024-03-06 | 16.8 | 2023-12-28 | 17.0 |
| 2024-03-05 | 16.8 | 2023-12-27 | 17.0 |
| 2024-03-04 | 16.8 | 2023-12-26 | 16.8 |
| 2024-03-01 | 16.8 | 2023-12-22 | 16.9 |
| 2024-02-29 | 17.0 | 2023-12-21 | 17.0 |
| 2024-02-28 | 17.0 | 2023-12-20 | 17.0 |
| 2024-02-27 | 17.1 | 2023-12-19 | 16.8 |
| 2024-02-26 | 17.1 | 2023-12-18 | 17.2 |
| 2024-02-23 | 17.1 | 2023-12-15 | 16.8 |
| 2024-02-22 | 16.9 | 2023-12-14 | 17.0 |
AstraZeneca PLC (BSP:A1ZN34) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
AstraZeneca PLC
ISIN : BRA1ZNBDR003
Share Class Description:
BSP:A1ZN34: BRDRCompare
Compare
Traded in other countries / regions
AZN.USAAZN.UKAZN.SwedenZEG.GermanyA1ZN34.BrazilAZNN.MexicoAZNA.AustriaAZN.Argentina IPO Date
2020-10-19Description
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers